Here’s a detailed account of the development spanning over thirty years: https://www.aaas.org/news/road-lenacapavir-breakthrough-hiv-treatment https://www.aaas

Here’s a detailed account of the development spanning over thirty years: https://www.aaas.org/news/road-lenacapavir-breakthrough-hiv-treatment https://www.aaas.org/news/road-lenacapavir-breakthrough-hiv-... Seems to be a combination of university funding (University of Utah), big pharma (Gilead), and global HIV advocacy groups working together. Sadly this kind of university research and non-profit advocacy groups are both prime targets of the Trump administration’s funding cuts. The next breakthrough drugs may have to be developed in some other country.